ACTRN12619000513112
Recruiting
未知
An observational study investigating and auditing the safety, tolerability and further efficacy characteristics of a pharmaceutical grade cannabis medicine (NanaBis™) prescribed to eligible patients for the management of cancer related or non-cancer related pain in general and specialty medical practices.
Medlab Clinical0 sites2,000 target enrollmentApril 1, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cancer related pain
- Sponsor
- Medlab Clinical
- Enrollment
- 2000
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Prospective participants greater than or equal to 18 years of age at time of entry on study;
- •2\.Prospective participants have the cognitive ability to understand the informed consent process and to give informed consent to participate in the observational study;
- •3\.Prospective participants have been lawfully prescribed NanaBis™ by their Consenting Doctor;
- •4\.Prospective participants are prescribed NanaBis™ for the management of cancer related or non\-cancer related pain;
- •5\.Prospective participants are able to visit the Consenting Doctor as required while administering NanaBis™ and are able to provide information as required to the Consenting Doctor for the duration of the study;
- •6\.Prospective participants agree to abstain from using cannabis products other than NanaBis™ for the duration of their participation in the study.
Exclusion Criteria
- •1\.Prospective participants will be ineligible if they are under the age of 18 years;
- •2\.Prospective participants will be ineligible if they are unwilling or unable to sign the Informed Consent Form or cannot understand the Participant Information Sheet provided;
- •3\.Prospective participants will be ineligible if the Consenting Doctor determines that the prospective participant is unable to fulfill any of the requirements of the study;
- •4\.Prospective participants will be ineligible if they are unwilling or unable to perform study procedures as described in the study protocol.
- •5\. Prospective participants will be ineligible if they are currently using Illicit drugs and/or with alcohol abuse.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
An exploratory observational study to investigate patient background factors of Ramelteon respondersJPRN-UMIN000013271Takeda Pharmaceutical Company Limited2,200
Not yet recruiting
Not Applicable
An Observational and Analytical Study to Evaluate Heart Diseases with ECG,2D Echo and Fasting Lipid ProfileHealth Condition 1: I219- Acute myocardial infarction, unspecifiedHealth Condition 2: I019- Acute rheumatic heart disease, unspecifiedHealth Condition 3: I209- Angina pectoris, unspecifiedHealth Condition 4: I110- Hypertensive heart disease with heart failureHealth Condition 5: I798- Other disorders of arteries, arterioles and capillaries in diseases classified elsewhereHealth Condition 6: I089- Rheumatic multiple valve disease,unspecifiedCTRI/2023/08/056260Parul Institute of Ayurved
Completed
Not Applicable
How to grasp the amount of food for inpatients in a university hospitaloneJPRN-UMIN000048157niversity of Tsukuba197
Recruiting
Not Applicable
Observational study to compare the reliability and inter-observer variability of three imaging techniques (optical coherence tomography, intravascular ultrasound and angiography) used for stenting in a hospital set-up in India.CTRI/2019/12/022539Apex Heart Institute
Not yet recruiting
Not Applicable
Role and efficacy of non invasive ventilation in the management of type 2 respiratory failureCTRI/2023/07/055709The Signature Hospital